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S_ry Cytogenetic analysis was performed on short-term cell cultures of two foci (A and B) from each of
three multifocal breast carcinomas. In case I, four clones (three related and one unrelated) were detected in
sample A. In sample B, two of the three related clones and the unrelated cone seen in A were found, as was
also a third subclone showing a pattern of clonal evolution slightly different from that detected in A. In ca
II and 111, multiple cytogenetically unrelated clones were found in A and B, with only one clone being shared
by both foci in each case. Our finding of cytogentic smilarities between macroscopicary distinct tumour
ksions indicates that the multifocality rflects intramammary tumour spread rather than the synchronous
erenc of pathogenetically independent carc<iomas within the samc breast On the other hand, the
detection of karyotypic heterogeneity in the form of cytogenetically unrelated clones in al foci suggests that
human breast carcnoa may be polyclonal. This polyconality may be part of the explanation for the cllular
heterogeneity commonly seen at the phenotypic kvel in breast cancer.
Breast cancer is not only a common and often deadly disease,
but one that is noted for its clinical unpredictability (Harris
et al., 1992). One of the striking facets of breast carcinomas
is the pronounced phenotypic heterogeneity that exists
among the cells of any given tumour; this feature has not
been satisfactorily explained (Wolman & Heppner, 1992).
Another intriguing aspect is the multifocal distibution of the
tumour tissue, with various degrees of histological differences
among the foci, in perhaps as many as half of all breast
cancer cases (Holland et al., 1985; Dawson, 1993). This
multifocality is of profound interest from at least two per-
spectives. First, with the advent in recent years of breast-
conserving surgery as a major therapeutic modality it has
become increasingly important to know how frequently
tumorous lesions are left behind, and how likely these are to
give rise to local recrencs. Second, the pathogenetic im-
plications of the observed multifocality must receive due
attention. Is it the result of intramanmary spread from a
single primary tumour or are we witnesig synchronous
malignant transformation in a field of epithelial cells?
Some data indiate that acquired genetic differences play a
major role in generating phenotypic heterogeneity in breast
carcinomas, be they multifocal or not. Measurements of
DNA content have demonstrated that genomic differences
exist within tumours: multiple DNA stlines were detected
in 40% of intraductal breast carcinomas by image cytopho-
tometric DNA analysis (Crissman et al., 1990) and flow
cytometric variation in the DNA histograms among distinct
tumour samples was reported by Kallioniemi (1988) and
Fuhr et al. (1991). The latter investigators empha the
need to analyse multiple sampks if anything approaching a
correct and complete picture of the tumour's genome is to be
achieved.
Cytogenetic studies are unique in revealing the karyotypic
constitution of individual tumour cells and should be able to
yield valuable information on the heterogeneity probeim, but
almost all reports have refrained from addressing the ques-
tion directly. Some findings are very suggestive, however,
Pandis et al. (1993a) detected multiple (related or unrelated)
clones in more than half of karyotypically abnormal primary
breast carcinomas. To examine further the prevalenc and
nature of intratumour heterogeneity and multiclonality in
breast carcinoma, we karyotyped macroscopically distict
tumour lesions from each of three women with multifocal
disease. To the best of our knowledge, this is the first time
that such a study has been undertaken in breast cancer.
Materals ad --po
From each of three breast carcinomas in three women, histo-
pathological and cytogenetic analyses were performed on two
tissue sampls, A and B. The carcinomas were multifocal in
all three cases, with one main tumour mass (from which the
A sample was taken) and one macroscopically distinct,
usually smaller, tumour lesion (sample B). The histopatho-
logical clasification, which was also based on examination of
slides immediately adjacent to the samples processed for
cytogenetic investigation, was made in accordance with WHO
recommendations (Sobin, 1981). Cells from the material
intended for cytogenetic study were short-term cultured and
analysed as described by Pandis et al. (1992a). The clonality
criteria and the description of karyotypes followed the
recommendations of the ISCN (1991). The histopathological
diagnosis was made without knowledge of the karyotypic
abnormalities.
Case histories
Case I The patient was 45 years old when a tumour was
found in her right breast. The histopathologial examination
revealed a comedo-type ductal carcinoma in A (10 mm
in diameter) and, in focus B, which also measured 10 mm, a
ductal carcnoma in situ with intralymphatic tumour emboli.
The two foci were separated by more than 1 cm of macro-
scopicaly normal breast tissue. There were no lymph node or
distant metastases.
Case H A multifocal tumour was detected in the right
breast of a 68-year-old woman. The A focus measured
23 mm in diameter, the B focus 15 mm. The histopatho-
logical examination revealed a tubuloductal carcinoma in A
and a ductal carcinoma in situ with areas of severe epithelial
hyperplasia in B. The two foci were separated by 0.5 cm of
grossly normal breast tissue. There were no lymph node or
distant metastases.
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Case III A 68-year-old woman had a multifocal tumour
excised from her left breast. The A focus measured 20mm in
diameter, the B focus 15 mm. The histopathological examina,
tion showed a lobular carcinoma in A and a lobular car-
cinoma with areas of severe epithelial hyperplasia in B. The
two foci were separated by more than 1 cm of grossly normal
tissue. There were no lymph node or distant metastases.
Resits
Complete karyotype data are given in Table I. Multiple
cytogenetically unrelated clones were found in each of the
three cases. Moreover, clonal differences as well as
similarities between the two foci were detected in all cases
(Figures 1-3).
In case I, 50 metaphases from each sample were karyo-
typed. Four clones were found in sample A: three (la, lb and
Ic; Table I) highly complex, related clones and one unrelated
clone (2) with only a simple structural abnormality. In sam-
ple B, two of the three related clones present in A were
identified (la and lb), but also a third subclone (ld), show-
ing a pattern of clonal evolution partly different from that
detected in sample A, was found. In addition, the unrelated
clone seen in A (2) was identified as a clone in the B sample
too, as were also two other unrelated clones (3 and 4). Four
and seven cells with non-clonal changes were found in sam-
ples A and B respectively. A normal female complement was
found in four metaphases in A and in 14 metaphases in B. In
addition to the completely analysed cells in each sample, all
the remaining metaphases detected (250 in A and 300 in B)
were screened for the presence of the clonal aberrations
found in the opposite sample; thus the total number of
metaphases examined in case I was 650.
In case 1I, 50 metaphases were karyotyped from each
sample. Two and three unrelated clones were found in sam-
ples A and B respectively; only one of these clones (1) was
present in both A and B. Twenty-five and 24 cells with
non-clonal abnormalities were detected in samples A and B
respectively. A normal female complement was found in 16
cells in A and in 17 cells in B. The remaining available
metaphases (650 in A and 350 in B) were screened for the
existence of the clones detected in the opposite sample, mak-
ing the total number of cells examined 1,100.
In case m, 100 cells were karyotyped from each of the two
foci. Two abnormal and cytogenetically unrelated dones
were detected m each sample. As in the previous case, only
one clone (1) was shared by both samples. In both A and B,
three cells with non-clonal aberrations were detected. A nor-
mal female complement was found in 68 metaphases in sam-
ple A and in 58 metaphases in sample B. All identified
additional metaphases (110 in A and 80 in B) were screened
for the clonal abnormalities present in the opposite sample,
making the total number of cefls examined 390.
At least one clone common to both foci was detected in all
three multifocal breast carcinomas. This is strong evidence
that the multifocality was due to intramammary spread from
a single primary tumour and not to the synchronous
emergence of pathogenetically independent carcinomas. The
mechanism whereby the multifocality arises remains poorly
understood, but embolisation of clumps of neoplastic cells
into lymphatic vessels probably played a role in case I, in
which numerous intralymphatic tumour emboli were detected
histologically in sample B.
However, besides the detection in each case of interfocal
cytogenetic similarity, at least equally thought-provoking was
the finding of intra- and interfocal karyotypic heterogeneity
(Figure 1) in all three cases. How should the discovery of
such profound clonal heterogeneity influence our conceptual
model of breast carcinogenesis?
Multiple chromosomally abnormal clones have previously
been reported in 20 primary breast carcinomas. In six of
them, the clones were related (Gerbault-Seureau et al., 1987;
Saint-Ruf et al., 1990; Pandis et al., 1993a, b), but the rest
were cytogenetically unrelated (Dutrillaux et al., 1990;
Geleick et al., 1990; Pandis et al., 1993a; Thompson et al.,
1993). This karyotypic heterogeneity may at least partially
explain the remarkable phenotypic heterogeneity seen at the
cellular level in breast carcinomas (Heppner, 1984). The fre-
quency with which unrelated clones are identified in breast
carcinomas is obviously technique dependent; after the intro-
duction of improved methods for the short-term culture and
cytogenetic analysis of these tumours (Pandis et al., 1992a),
cytogenetically unrelated clones could be detected in one-
third to one-half of all cases with an abnormal chromosome
complement (Pandis et al., 1993a, 1994a).
Each focus from all three tumours of the present report
showed karyotypic multicdonality. The presence of four
related clones (la-d; Table I) in case I might be seen as
evidence of clonal evolution associated with tumour progres-
sion, i.e. the stepwise acquisition of different somatic muta-
tions resulting in the appearance of phenotypically disparate
subpopulations within a tumour (Nowell, 1986; Heim, 1993).
This type of intratumour cytogenetic heterogeneity fits com-
pletely interpretations of the somatic mutation theory of
tumorigenesis envisaging the evolutionary process as beginn-
ing with a single mutated cell. Similar examples of clonal
karyotypic divergence have been obtained also by studies of
samples of recurrent mesenchymal tumours taken on several
different occasions (Orndal et al., 1993a, b).
The cytogenetically unrelated clones may be explained in
different ways. A first-level dichotomy is whether one accepts
that all the clones are part of the tumour parenchyma or if
one stipulates that only one clone (or group of related clones)
is representative of the neoplasia. In this situation, the
unrelated abnormal clones would represent either non-neo-
plastic epithelial cells or stromal cells whose chromosomal
rearrangements might possibly have been induced by muta-
gens released by the neighbouring cancer cells. If all the
clones are truly neoplastc, on the other hand, those which
are cytogenetically unrelated could nevertheless stem from a
single transformed mother cell if they share the same submi-
croscopic mutation. This possibility seems highly unlikely,
however, considering the disparate nature of the observed
changes. Finally, the pathogntically important but cyto-
genetically unrelated clones could indeed be evolutionarily
unrelated, reflecting a polyclonal origin of the neoplasm.
Tlhere is presently no way to falsify conclusively any of the
hypotheses listed above, let alone corroborate any of them.
On balnce, however, we tend to favour the multiclonal
origin model as the one that best accommodates the data.
The findings in case I are particularly pertinent. There can be
little doubt about the pathogenetic relevance of the four
related clones la-d (the karyotype was complex, with no less
than 14 chromosomes involved in structural rearrangements;
Figure 2), but also some of the aberrations in the unreated
clones (Figure 3) are known to occur non-randomly in breast
cancer cells. The i(lXqlO) found in sample B in clonal pro-
portions has been registered in almost 10% of previously
reported cases (Mitelnan, 1994) and is known to occur also
as the sole chromosomal abnormality in a subset of breast
carcinomas karyotypically defined by net gain of Iq (Pandis
et al., 1992b). Likewise, chromosome band 3p13 (clone 4,
case I) is known to be frequently rearranged in breast cancers
and the two deletions del(lXql1) and del(6)(q21) (clones 1
and 3, case It) are also common in this tumour type (Pandis
et al., 1993b, 1994a), all of which constitutes circumstantial
evidence that these anomalies existed in cells that were part
of the neoplastic parenchyma. Doubts about the pathogenetic
role of these clones based on the fact that they encompassed
only a small number ofcells seem to us to be unfounded (see
below); at any rate, the clonal size argument cannot be used
for clone 2 of case I, which was large and with only a simple
structural rearrangement, but was present in both macro-
scopically distinct foci.
The data we present and the interpretation that they reflect924 M.R. TEIXEIRA etal.
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a multicellular tumour origin would seem to run counter to
the extensive body of evidence, obtained by both cytogenetic
and other methods, that tumorigenesis is monoclonal (Wains-
coat & Fey, 1990). In a study of 20 breast carcinomas using
polymerase chain reaction-based analysis of the X-linked
PGK gene, Noguchi et al. (1992) found the same X chromo-
some to be inactivated in each tumour, indicating that all the
carcinomas were monoclonal. However, this type of investi-
Tumour I
gation only detects a monoclonal component against a poly-
clonal background if the monoclonal cell population makes
up 50% of the total or more. The method therefore has an
inherent 'winner takes all' bias, and so the presence of addi-
tional, independent, smaller clones cannot be said to be ruled
out by the findings.
Cytogenetic support for the general conclusion that
tumours are monoclonal largely stems from investigations of
haematological and mesenchymal neoplasms. At the same
time, karyotypic evidence of polyclonality is increasingly
being found in carcinomas (Heim et al., 1989a; Jin et al.,
1990a, b; Pandis et al., 1992b, 1993a, b, 1994a; Bardi et al.,
1993), indicating that a fundamental pathogenetic difference
may exist between epithelial and other neoplasms. We would
like to emphasise that the karyotypic heterogeneity that has
been observed may well represent an underestimate of the
actual variation in tumour cell populations. First, the sample
for cytogenetic analysis may not include all tumour clones.
Since subpopulations originating from the same parent cell
probably tend to maintain contiguity in solid tumours, the
different clones are likely to be regionally localised within the
Sample A Sample B
Tumour 1I
Figwe 2 Metaphase plate from a cell belonging to the complex
related clones of case I.
Sample A Sample B
Tumour III
Sample A Sample B
Fugwe 1 Diagrammatic representation of the clonal differences
and similarities between the two samples (from separate tumour
foci) in each breast carcinoma. Partially overlapping circles repre-
sent related clones. Circles connected by lines represent the
presence of the same clone in both samples. The presence of the
same graphic patterns in the different cases does not reflect
similarity among the clones they represent.
Figwe 3 Partial karyotypes illustrating the chromosome abnor-
malities of the pseudo-diploid and near-diploid unrelated clones
of cases I-1II. From left to right: clones 2-4 of case I. clones
1-4 of case II and clones 1-3 of case III. See Table I for
karyotype descriptions.926 M.R. TEIXEIRA et al.
neoplasm. If so. the cytogenetic analysis of multiple samples
ought to increase the likelihood of detecting more than one
clone. Second. the doubling time in vitro of myoepithelial,
epithelial and cancer cells in breast tumours is, respectively,
24, 48 and more than 120 h (Petersen & van Deurs, 1987). Of
necessity. this must lead to the progressive dilution of the
cancer cell fraction in vitro (O'Hare, 1991; Pandis et al.,
1994b). Also various subpopulations of unquestionably
malignant mammary epithelial cells have been shown to have
different proliferation rates (Schmidt-Ullrich et al., 1986).
Third, and related to the point mentioned above, the special
environment facing tumour cells in culture introduces a
strong and stable selection pressure that tends to lead initially
heterogeneous cell populations towards pseudomonoclonality
or oligoclonality (Heim et al., 1989b). Fourth, the number of
metaphase cells that are analysed strongly influences the
likelihood of detecting small clones; if too few cells are
examined, the aberrations they contain might be dismissed as
non-clonal cytogenetic noise. This might be what happened
for tumour II of the present report, in which a high propor-
tion of non-clonal changes was found.
On the other hand, the finding of a single karyotypic clone
in an established carcinoma - this is, after all, the most
commonly reported situation (Mitelman, 1994) - is only a
weak indication that the tumour was also initially mono-
clonal: absence of evidence is no evidence of absence. Initial
multiclonality may well give way to pseudomonoclonality
when the selection forces in the tissue change, for example
when the neoplastic cells penetrate the basal lamina and start
to infiltrate locally (Heim et al., 1988). This kind of in vivo
Darwinian selection acting on the tumour cell population
during the various stages of neoplastic development and
progression could conceivably be the explanation for the
asymmetric distribution of the observed clones between the
foci in the three cases we describe. In vitro stochastic as well
as systematic factors such as those discussed in the foregoing
passages may equally well explain the interfocal differences,
however, which is why we do not dare to speculate further
on the evolutionary relationship between the tumour foci.
We conclude that the existing, admittedly very limited.
cytogenetic evidence indicates that multifocal breast car-
cinoma is the result of intramammary spread from a primary
tumour focus. The clonal nature of breast carcinomas re-
mains unresolved, and we second the conclusion of Devilee
and Cornelisse (1990) that the genetic study of multiple
tumour samples (be it at the genomic, chromosomal or genic
level) is necessary to gain reliable insight into the problem.
The few cytogenetic data that exist seem to indicate that at
least a subset of breast carcinomas are polyclonal. If borne
out in future studies, these results must have a profound
influence on how we envisage the pathogenetic process in this
tumour type. One possibility that comes to mind is that some
kind of clonal synergism might exist among the various
subsets of cells in the tumour parenchyma. To test this
possibility, for example by assessing tumorigenicity in nude
mice, one would need to have access to isolated cell lines
with each of the chromosomal abnormalities in question. The
effect of injecting them in various combinations could then
be investigated.
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